L. van Wulften

Prevalence of the metabolic syndrome and cardiovascular disease risk in chemotherapy-treated testicular germ cell tumour survivors

R. Huddart, F. Rosendaal, N. Weijl, 2013 .

Prevalence of the metabolic syndrome and cardiovascular disease risk in chemotherapy-treated testicular germ cell tumour survivors

F. Rosendaal, N. Weijl, J. Burggraaf, 2013, British Journal of Cancer.

Prevalence of the metabolic syndrome and cardiovascular disease risk in chemotherapy-treated testicular germ cell tumour survivors

F. Rosendaal, N. Weijl, J. Burggraaf, 2013, British Journal of Cancer.

Prevalence of vertebral fractures independent of BMD and anticancer treatment in patients with testicular germ cell tumors.

H. Putter, S. Osanto, P. Willemse, 2010, The Journal of clinical endocrinology and metabolism.

Prevalence of the metabolic syndrome and cardiovascular disease risk in chemotherapy-treated testicular germ cell tumour survivors

F. Rosendaal, N. Weijl, J. Burggraaf, 2013, British Journal of Cancer.

Prevalence of the metabolic syndrome and cardiovascular disease risk in chemotherapy-treated testicular germ cell tumour survivors

F. Rosendaal, N. Weijl, C. Y. Vossen, 2013, British Journal of Cancer.